HMGB1: Endogenous Danger Signaling
Authors:
- Rajeev DhuparRDRajeev Dhupar
- Jon CardinalJCJon Cardinal
- Timothy R. BilliarTBTimothy R. Billiar
- Allan TsungATAllan Tsung
Top Cited Papers
Open Access
- 11 April 2008
- journal article
- review article
- Published by Springer Nature in Molecular Medicine
- Vol. 14 (7-8) , 476-484
Abstract
While foreign pathogens and their products have long been known to activate the innate immune system, the recent recognition of a group of endogenous molecules that serve a similar function has provided a framework for understanding the overlap between the inflammatory responses activated by pathogens and injury. These endogenous molecules, termed alarmins, are normal cell constituents that can be released into the extracellular milieu during states of cellular stress or damage and subsequently activate the immune system. One nuclear protein, High mobility group box-1 (HMGB1), has received particular attention as fulfilling the functions of an alarmin by being involved in both infectious and non-infectious inflammatory conditions. Once released, HMGB1 signals through various receptors to activate immune cells involved in the immune process. Although initial studies demonstrated HMGB1 as a late mediator of sepsis, recent findings indicate HMGB1 to have an important role in models of non-infectious inflammation, such as autoimmunity, cancer, trauma, and ischemia reperfusion injury. Furthermore, in contrast to its pro-inflammatory functions, there is evidence that HMGB1 also has restorative effects leading to tissue repair and regeneration. The complex functions of HMGB1 as an archetypical alarmin are outlined here to review our current understanding of a molecule that holds the potential for treatment in many important human conditions.Keywords
This publication has 127 references indexed in Scilit:
- HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signalingJournal of Experimental Medicine, 2007
- The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapyImmunological Reviews, 2007
- Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activationJournal of Cell Biology, 2007
- TLR4 activation mediates kidney ischemia/reperfusion injuryJournal of Clinical Investigation, 2007
- A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNABlood, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- A novel pathway of HMGB1‐mediated inflammatory cell recruitment that requires Mac‐1‐integrinThe EMBO Journal, 2007
- Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1Journal of Leukocyte Biology, 2006
- Alarmin(g) news about dangerEMBO Reports, 2006
- Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host responseJournal of Leukocyte Biology, 2006